Yadav Shyamlal Singh, Patgiri Biswajyoti, Prajapati Pradeep Kumar
Ph.D. Scholar, Department of Rasa Shastra and Bhaishajya Kalpana, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Ayu. 2012 Apr;33(2):255-60. doi: 10.4103/0974-8520.105247.
Incidences of Bronchial Asthma have been raised in recent decades due to increased industrialization and pollution. This miserable condition can be compared with Tamaka Shwasa in Ayurveda. Modern synthetic drugs will provide instant relief in these cases, but are tend to develop a number of adverse drug reactions. Knowing this, the current suffering population is looking towards few remedies from other systems of medicines, that are comparatively safe and provide better relief. Shirisha [Albizzia lebbeck Benth] is a drug with multi-dimensional activities emphasized in Ayurveda for different disease conditions. Considering this, two types of Shirishavaleha (confection of Shirisha) were prepared by Kwatha (decoction) of Twak (bark) and Sara (heartwood) of Shirisha to evaluate its comparative efficacy in Tamaka Shwasa (bronchial asthma). The results were assessed in terms of clinical recovery, symptomatic relief and pulmonary function improvement. A significant increase in Hb and considerable decrease in total eosinophil count, AEC and ESR were observed. The study revealed that Shirishavaleha can be used as an effective drug in bronchial asthma.
近几十年来，由于工业化进程加快和污染加剧，支气管哮喘的发病率有所上升。这种令人痛苦的病症可与阿育吠陀医学中的“Tamaka Shwasa”相类比。现代合成药物能在这些病例中提供即时缓解，但往往会引发多种药物不良反应。鉴于此，当前的患者群体正期待从其他医学体系中寻找一些相对安全且能提供更好缓解效果的疗法。Shirisha [阔荚合欢（Albizzia lebbeck Benth）] 是一种在阿育吠陀医学中针对不同病症具有多种功效的药物。考虑到这一点，通过将Shirisha的树皮（Twak）和心材（Sara）煎煮制成Kwatha（汤剂），制备了两种类型的Shirishavaleha（Shirisha的糖膏剂），以评估其在Tamaka Shwasa（支气管哮喘）中的相对疗效。结果从临床康复、症状缓解和肺功能改善等方面进行评估。观察到血红蛋白显著增加，总嗜酸性粒细胞计数、绝对嗜酸性粒细胞计数和红细胞沉降率显著降低。研究表明，Shirishavaleha可作为治疗支气管哮喘的有效药物。
